Top Markets
Coin of the day
Nordicus Partners Corporation Nordicus Partners Corporation

Nordicus Partners Corporation

NORD
Kedudukan dalam Saham #23226
Nordicus Partners Corporation functions as a publicly traded entity that acts... Nordicus Partners Corporation functions as a publicly traded entity that acts as both a business accelerator and a holding company, specifically supporting Nordic life sciences firms operating within the United States. A central focus for the company involves advancing oral healthcare through the development of new medicines. In addition to its core operations, Nordicus offers an array of corporate finance and advisory services. These include aiding in business and market expansion, formulating strategic growth plans, identifying and acquiring talent, fostering key partnerships, facilitating capital raising efforts, and orchestrating company acquisitions or sales. The organization, which was established in 1993 and is headquartered in Beverly Hills, California, rebranded as Nordicus Partners Corporation in May 2023, having previously been known as EKIMAS Corporation.
Harga Saham
$4.06
Disegerakkan terakhir: 2026-08-21
Modal Pasaran
$76.69M
Perubahan (1 hari)
-0.98%
Perubahan (1 tahun)
125.56%
Negara
US
Perdagangan Nordicus Partners Corporation (NORD)

Kategori

Hasil untuk Nordicus Partners Corporation (NORD)
Hasil pada Aug 2026 TTM: 0
Menurut laporan kewangan terkini daripada Nordicus Partners Corporation, hasil semasa syarikat (TTM) ialah 0. Pada tahun 2026, syarikat memperoleh hasil sebanyak 0 sama dengan hasil pada tahun 2026 iaitu 0. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Nordicus Partners Corporation dari 2026 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
$6.52B -
CH
$6.44B -
US
$7.75B -
FR
$6.46B -
US
$11.09B -
US